Referencer

1. Nebido^® Produktresuméet 2017-05-01.
2. Sartorius G, Fennell C, Spasevska S, et al. Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate. Asian J Androl 2010;12(2):227–233.
3. Middleton T, Turner L, Fennell C, et al. Complications of injectable testosterone undecanoate in routine clinical practice. Eur J Endocrinol 2015;172(5):511–517.

Indberet alle formodede bivirkninger af testosteronundekanoat (Nebido) til Bayer A/S eller Lægemiddelstyrelsen.